TriSalus Life Sciences (TLSI) Gains from Investment Securities (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Gains from Investment Securities of -$7.4 million for Q1 2026, down 1002.68% year-over-year from $820000.0 in Q1 2025, and down 243.81% quarter-over-quarter from $5.1 million in Q4 2025.
TriSalus Life Sciences (TLSI) Gains from Investment Securities (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Gains from Investment Securities history runs 5 years deep, the most recent figure standing at -$7.4 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 1002.68% year-over-year to -$7.4 million; the TTM figure through Mar 2026 stood at -$5.5 million (up 61.95% YoY), while the FY2025 annual figure was $2.7 million, up 124.42% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$7.4 million, down from $5.1 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $9.6 million in Q4 2023, with the low at -$19.9 million in Q3 2023.
- The 5-year median for Gains from Investment Securities is -$1.5 million (2024), against an average of -$2.4 million.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities surged 520.12% in 2025, then slumped 1002.68% in 2026.
- TriSalus Life Sciences' Gains from Investment Securities stood at -$2.4 million in 2022, then jumped by 502.47% to $9.6 million in 2023, then tumbled by 91.36% to $830000.0 in 2024, then soared by 520.12% to $5.1 million in 2025, then sank by 243.81% to -$7.4 million in 2026.
- Business Quant data shows TLSI's Gains from Investment Securities at -$7.4 million in Q1 2026, $5.1 million in Q4 2025, and -$2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 996,000.00 |
| Jun 30, 2026 | 996,000.00 |
| Mar 31, 2026 | -7.40 Mn |
| Mar 31, 2026 | -7.40 Mn |
| Dec 31, 2025 | 5.15 Mn |
| Dec 31, 2025 | 5.15 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -700,000.00 |
| Jun 30, 2025 | -700,000.00 |
| Mar 31, 2025 | 820,000.00 |
| Mar 31, 2025 | 820,000.00 |
| Dec 31, 2024 | 830,000.00 |
| Dec 31, 2024 | 830,000.00 |
| Sep 30, 2024 | -2.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Jun 30, 2024 | -13.69 Mn |
| Mar 31, 2024 | 3.99 Mn |
| Mar 31, 2024 | 3.99 Mn |